Mild COVID-19 manifestation in multiple risk factor patient on
methotrexate, who had been treated with UVB phototherapy and had
sufficient plasma 25-OH-vitamin D3 level
- Martina Kralj,
- Hrvoje Jakovac
Abstract
We report mild COVID-19 manifestation in high-risk patient with
sufficient plasma 25-OH-Vitamin D3 level. Given the global pandemic of
vitamin D deficiency, as well as its likely beneficial effects during
SARS-CoV-2 infection, report highlights importance of routine
25-OH-Vitamin D3 measurement, either for clinical course prediction or
deciding on supplementation.17 Jan 2021Submitted to Clinical Case Reports 20 Jan 2021Submission Checks Completed
20 Jan 2021Assigned to Editor
31 Jan 2021Reviewer(s) Assigned
04 Feb 2021Review(s) Completed, Editorial Evaluation Pending
11 Feb 2021Editorial Decision: Revise Minor
14 Feb 20211st Revision Received
15 Feb 2021Submission Checks Completed
15 Feb 2021Assigned to Editor
15 Feb 2021Review(s) Completed, Editorial Evaluation Pending
16 Feb 2021Reviewer(s) Assigned
22 Feb 2021Editorial Decision: Accept
